Alia Abdel-Razeq, the Chief Operating Officer at CellSave Arabia, stands as a prominent figurehead in the forefront of the stem cell and regenerative medicine revolution in the Middle East. She has a background rooted in chemical and pharmaceutical engineering, complemented by extensive experience in healthcare management and research. Under Alia’s insightful leadership, CellSave Arabia has expanded its offerings to cater comprehensively to the diverse needs of individuals and institutions. Notably, a groundbreaking addition is newborn stem cell storage for longevity purposes, empowering families with future-use options with stem cells and stem cell-derived exosomes. Furthermore, CellSave Arabia is pioneering stem cell therapy services, revolutionizing treatments for conditions such as autoimmune disorders, heart disease, neurological ailments, regenerative medicine, and more.
General Inquiries
Forbes Middle East is a licensee of Forbes Media and extends the Forbes brand of journalism across the Arab world. Forbes Middle East’s distinctive editorial style attracts a readership of Arab leaders, entrepreneurs, C-level executives, government officials and investors united by a belief in the spirit of free enterprise and entrepreneurial values.Across the region, Forbes Middle East sets the pace for preemptive business journalism. By uncovering trends and anticipating opportunities in the regional marketplace, each monthly issue brings top executives the information critical to their success – in both Arabic and English language editions. The magazine researches and publishes original rankings, based on methodologies set by Forbes Media.